Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answers of 9 July 2014, Official Report, column 313W, on ovarian cancer and 24 June 2014, Official Report, columns 156-7W, on ovarian hyperstimulation syndrome, if his Department will collect data on the number of women admitted to hospital with ovarian hyperstimulation syndrome (OHSS); if he will take steps to ensure systematic reporting of OHSS from egg sharing and egg donation; if he will make it his policy that ovarian hyperstimulation syndrome be notifiable; and if he will take steps to ensure that women are accurately informed of the risk of hospitalisation from OHSS when considering egg donation or egg sharing procedures.

Collection of data relating to treatments regulated by the Human Fertilisation and Embryology Act 1990, as amended, and the recording of serious adverse clinical reactions come within the statutory duties of the Human Fertilisation and Embryology Authority (HFEA).

At its meeting on 9 July 2014, the HFEA agreed a new strategy for 2014-2017, which sets out its regulatory focus. Also at that meeting, the Authority members agreed to give consideration to the collection of additional data when a case of Ovarian Hyperstimulation Syndrome is reported. The HFEA will take expert scientific and medical advice on whether such data collection would be of value and on the feasibility of collecting reliable information.

The papers for the meeting and an audio record of the discussions can be found on HFEA’s website at:

www.hfea.gov.uk/Authority-July-2014.html